Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
IPA - 1.58 Pre-market at 2.26/2.27
IPA’s subsidiary BioStrand Unveils Major Breakthrough in Life Sciences with Advanced Foundation AI Model Utilizing LLM Stacking and HYFT Technology
BENF - .10 Pre-market at .1625/.1629
Beneficient Agrees To The Financing Of Liquidity Transactions For Three Separate Funds Managed By ff Venture Capital
BREA - 1.02 Pre-market at 2.37/2.38
Brera Holdings shares are trading higher after the company announced that its Executive Chairman, Daniel McClory, acquired a majority stake in the company.
PHGE - .2311 Pre-market at .87/.88
BiomX Enters Merger Agreement With Adaptive Phage Therapeutics n Stock-For-Stock Transaction And Concurrent $50 Million Private Placement Financing; Former Stockholders Of BiomX Will Own Approximately 55% And The Former Stockholders Of APT Will Own Approximately 45% Of The Consolidated Entity
TPST - 3.17 Pre-market at 3.32/3.38
Tempest Announces Upcoming Presentation Of Preclinical Data For TPST-1120 In Renal Cell Carcinoma At AACR Annual Meeting
LLAP - 1.17 Pre-market at 1.27/1.28
Terran Orbital Awarded Up To $45M IDIQ By NASA To Support Space Technology Advancement
CELZ - 4.129 Pre-market at 5.70/5.86
Creative Medical Technology Receives FDA Orphan Drug Designation For CELZ-101 In Key Transplantation Therapy
🔥 $IQST on Fire! 2023 brought a 50% revenue surge to $140M, and we haven't even factored in QXTEL yet! RPS jumped from $0.57 to $0.81 - talk about growth! Positive operating income, thriving gross margin, and whispers of a NASDAQ listing. Buckle up for a stronger position!
https://pubcoinsight.com/iqstels-profitability-growth-surge-a-compelling-play-for-traders-and-long-term-investors/
$IVDN: Specifier Magazine has profiled new building code requirements for Continuous Insulation. Innovative Designs' Insultex® meets these new codes where competitive products do not. Insultex® also delivers an unmatched R-6 Rating. Learn more at: http://insultexhousewrap.com
$IVDN: Specifier Magazine has profiled new
— Innovative Designs, Inc (Stock: $IVDN) (@riccelli_joseph) March 4, 2024
building code requirements for Continuous Insulation. Innovative Designs' Insultex® meets these new codes where competitive products do not. Insultex® also delivers an unmatched R-6 Rating. Learn more at: https://t.co/LWNDwJcXDh https://t.co/iYnREarHQ2
AISP - 1.65 Pre-market at 2.44/2.46
Airship AI Announces Significant Sole-Source Contract Award within the Department of Justice for Acropolis Enterprise Video and Data Management Platform
MNTS - .78 Pre-market at .9122/.9179
Momentus Awarded NASA Contract to Provide Flight and Payload Integration Services
PHUN - 12.41 Pre-market at 16.56/16.57
What's Going On With Phunware Shares After Donald Trump Wins In Multiple Republican Caucuses?
LVTX - 3.03 Pre-market at 3.34/3.35
LAVA Therapeutics shares are trading higher after the company announced a $7 million payment because Pfizer achieved a clinical milestone for PF-08046052.
CASI - 5.085 Pre-market at 7.16/7.225
CASI Pharma Shares Soar After Positive Preliminary Trial Data for Cancer Immunotherapy
BBAI - 4.41 Up .95
Social Buzz: Wallstreetbets Stocks Advance Premarket; BigBear.ai, Super Micro Computer Poised for Gains
HSDT - 5.96 Up 1.40
Helius Medical Technologies Announced It Secured HCPCS Codes for Portable Neuromodulation Stimulator Mouthpiece And Controller
PHUN - 11.94 Up 4.72
Phunware Expands Hospitality Portfolio Via A Multi-Year Partnership With Escapades Memphrémagog And PAL+
RNLX - 1.57 Pre-market at 1.58/1.59
Renalytix Earlier Announced It Has Received An Unsolicited Approach From A Large And Well-Capitalized Publicly Listed Strategic Diagnostics Company
QNRX - 5.46 Up 2.65
Quoin Pharmaceuticals shares are trading higher after the company announced FDA clearance to recruit teen subjects into both of its ongoing Netherton Syndrome clinical studies.
OT: Dr. this AM....getting a later start.
Must Watch - $GOLD - 12 years in the making )
By: TrendSpider | March 2, 2024
• 12 years in the making. $GLD
NYC PROTEST BEGINS🔥TRUCKERS BLOCK NEW YORK! TRUMP WINS SUPREME COURT SIDES TRUMP. NY GOV KATHY WARNS
https://rumble.com/v4gz9xr-nyc-protest-beginstruckers-block-new-york-trump-wins-supreme-court-sides-tr.html
This Is Why The U.S. Must Consider Returning To The Gold Standard
https://www.forbes.com/sites/steveforbes/2023/03/17/this-is-why-the-us-must-consider-returning-to-the-gold-standard/?sh=77a36e6daa24
https://twitter.com/intent/post?url=https%3A%2F%2Fwww.forbes.com%2Fsites%2Fsteveforbes%2F2023%2F03%2F17%2Fthis-is-why-the-us-must-consider-returning-to-the-gold-standard%2F&text=This%20Is%20Why%20The%20U.S.%20Must%20Consider%20Returning%20To%20The%20Gold%20Standard%20via%20%40forbes
12 years in the making. $GLD 🥇
— TrendSpider (@TrendSpider) March 3, 2024
Weekly newsletter out tomorrow, sign up for free.
📬 https://t.co/QzvevHvbNs pic.twitter.com/KmlPSJVegT
ENVB - 1.45 Pre-market at 1.55/1.56
Enveric Biosciences shares are trading higher after the company announced it signed three non-binding term sheets to pursue the out-licensing of three classes of compounds.
FUBO - 2.07 Pre-market at 2.26/2.27
FuboTV shares are trading higher after the company reported better-than-expected Q4 earnings and FY24 revenue outlook.
CRDF - 1.765 Pre-market at 2.12/2.13
Cardiff Oncology shares are trading higher after the company reported better-than-expected Q4 financial results, provided a clinical update on the Phase 2 randomized second-line ONSEMBLE trial in patients with RAS-mutated mCRC and announced the first patient was dosed in the randomized first-line RAS-mutated mCRC trial.
ADIL - 2.04 Pre-market at 3.50/3.51
Adial Pharmaceuticals shares are trading higher after the company announced that it was awarded a new patent covering AD04 for the potential treatment of opioid use disorder.
NXU - .7992 Pre-market at 1.31/1.32
Nxu Achieves North American Charging Standard Charging Milestone With Tesla Cybertruck
On the Conrad info, I have some disorganized but granular info posted on SA- the Q1 2017 report. It is the only comment there. I put it there for a reason that isn’t too important but anyway, that is where some info is.
We hope you all are doing well.
ZVSA - .99/1.02
HC Wainwright & Co. Reiterates Buy on ZyVersa Therapeutics, Maintains $24 Price Target
RVSN - 2.90 Pre-market at 4.75/4.78
Rail Vision Joins NVIDIA Metropolis to Boost Railway Safety Systems
NRBO - 5.12 Pre-market at 5.52/5.57
NeuroBo Pharmaceuticals Receives First Site IRB Approval For Its Phase 1 Clinical Trial Evaluating DA-1726 For Treatment Of Obesity
NOTE: This service still acts sluggish after not being able to accept posts all day yesterday. I hope this gets better.
SIDU - 5.57 Pre-market at 6.70/6.80
Sidus Space LizzieSat Satellite Encapsulated And Launch Scheduled
LASE - 1.04 Pre-market at 1.17/1.18
Laser Photonics Scores Order from Pima Air & Space Museum for Its CleanTech Laser Cleaning System
AGFY - .484 Pre-market at .6359/.6486
Agrify Corporation Announces $3.4 Million Sales Order From New Jersey Woman-Owned Business HarvestWorks Farm
NXU - .7096 Pre-market at .8205/.825
Nxu Signsed LOI With Electric Outdoors To Revolutionize EV Camping, Combining NxuOne(Charging Systems With EO Canopy Solar Units
ENVB - .831 Pre-market at 2.28/2.29
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of Three Classes of Compounds
VKTX - 38.48 Pre-market at 68.60/69.55
Viking Therapeutics Shares Double on Promising Weight-Loss Drug Trial
AULT - .3899 Pre-market at .555/.5588
Press Release: Ault Alliance Announces Record Preliminary 2023 Revenue of $153 Million, up 30% from 2022
SPRC - 3.74 Pre-market at 4.06/4.08
SciSparc-Clearmind Partnership Yields Three New International Patent Applications for MDMA, Ibogaine and Ketamine Compounds
BBAI- 2.49 Pre-market at 2.70/2.71
BigBear.Ai shares are trading higher. The stock may be rising amid continued volatility in AI stocks.
SOUN - 5.75 Pre-market at 6.98/6.99
SoundHound AI shares are trading higher. The stock may be rising amid continued volatility in AI stocks.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |